Stents as sole therapy for oesophageal cancer: a prospective analysis of outcomes after placement

The Lancet Oncology

Volumn 10, Issue 3, 2009, Pages 240-246

  White, Russell E ^a,b   Parker, Robert K ^a,c   Fitzwater, John W ^a,d   Kasepoi, Zachariah ^a   Topazian, Mark ^e  

^a Tenwek Hospital   (Kenya)

^b RHODE ISLAND HOSPITAL   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; DYSPHAGIA; ESOPHAGUS CANCER; ESOPHAGUS HEMORRHAGE; ESOPHAGUS OBSTRUCTION; ESOPHAGUS PERFORATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF EXPANDING METAL STENT; STENT; SURVIVAL RATE; SURVIVAL TIME; THORAX PAIN; TRACHEOESOPHAGEAL FISTULA; AGED; COHORT ANALYSIS; ESOPHAGUS TUMOR; MIDDLE AGED; MORTALITY; TREATMENT OUTCOME;

METAL;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; METALS; MIDDLE AGED; PROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 62849113100     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70004-X     Document Type: Article

References (41)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Pisani P., Parkin D.M., Bray F., and Ferlay J. Estimates of worldwide mortality from 25 cancers in 1990. Int J Cancer 83 (1999) 18-29
3. White R.E., Abnet C.C., Mungatana C.K., and Dawsey S.M. Oesophageal cancer: a common malignancy in young people of Bomet District, Kenya. Lancet 360 (2002) 462-463
4. White R.E., Kasepoi Z., Harewood G.C., Ng T., Cioffi W., and Topazian M. Experience with 1,345 esophageal cancer patients seen at a single mission hospital in western Kenya. Gastrointest Endosc 63 (2006) AB124
5. Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 281 (1999) 1623-1627
6. Kmietowicz Z. Tackle cancer in Africa now to prevent catastrophe, say health activists. BMJ 334 (2007) 1022-1023
7. Baron T. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 344 (2001) 1681-1687
8. Conio M., Repici A., Battaglia G., et al. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol 102 (2007) 2667-2677
9. White R.E., Mungatana C., and Topazian M. Esophageal stent placement without fluoroscopy. Gastrointest Endosc 53 (2001) 348-351
10. White R.E., Mungatana C., and Topazian M. Expandable stents for iatrogenic perforation of esophageal malignancies. J Gastrointest Surg 7 (2003) 715-720
11. Ogilvie A.L., Dronfield M.W., Ferguson R., and Atkinson M. Palliative intubation of oesophagogastric neoplasms at fiberoptic endoscopy. Gut 12 (1982) 1060-1067
12. Pfau P.R., Ginsberg G.G., Lew R., Faigel D.O., Smith D.B., and Kochman M.L. Esophageal dilation for endosonographic evaluation of malignant esophageal strictures is safe and effective. Am J Gastroenterol 95 (2000) 2813-2815
13. Schwer A.L., Ballonoff A., McCammon R., Rusthoven K., D'Agostino R.B., and Schefter T.E. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study. Int J Radiat Oncol Biol Phys 72 (2008) 449A-455A
14. Bedenne L., Michel P., Bouche O., et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25 (2007) 1160-1168
15. Homs M.Y., Steyerberg E.W., Eijkenboom W.M., et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 364 (2004) 1497-1504
16. Vakil N., Morris A.I., Marcon N., et al. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 96 (2001) 1791-1796
17. Hills K.S., Chopra K.B., Pal A., and Westaby D. Self-expanding metal oesophageal endoprostheses, covered and uncovered: a review of 30 cases. Eur J Gastroenterol Hepatol 10 (1998) 371-374
18. Xinopoulos D., Dimitroulopoulos D., Tsamakidis K., et al. Palliative treatment of advanced esophageal cancer with metal-covered expandable stents. A cost-effectiveness and quality of life study. J BUON 10 (2005) 523-528
19. Johnson E., Enden T., Noreng H.J., et al. Survival and complications after insertion of self-expandable metal stents for malignant oesophageal stenosis. Scand J Gastroenterol 41 (2006) 252-256
20. Riccioni M.E., Shah S.K., Tringali A., et al. Endoscopic palliation of unresectable malignant oesophageal strictures with self-expanding metal stents: comparing Ultraflex and Esophacoil stents. Dig Liver Dis 34 (2002) 356-363
21. Christie N.A., Buenaventura P.O., Fernando H.C., et al. Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up. Ann Thorac Surg 71 (2001) 1797-1801
22. Gevers A.M., Macken E., Hiele M., and Rutgeerts P. A comparison of laser therapy, plastic stents, and expandable metal stents for palliation of malignant dysphagia in patients without a fistula. Gastrointest Endosc 48 (1998) 383-388
23. Cwikiel W., Tranberg K.G., Cwikiel M., and Lillo-Gil R. Malignant dysphagia: palliation with esophageal stents-long-term results in 100 patients. Radiology 207 (1998) 513-518
24. De Palma G.D., Galloro G., Sivero L., et al. Self-expanding metal stents for palliation of inoperable carcinoma of the esophagus and gastroesophageal junction. Am J Gastroenterol 90 (1995) 2140-2142
25. Winkelbauer F.W., Schöfl R., Niederle B., Wildling R., Thurnher S., and Lammer J. Palliative treatment of obstructing esophageal cancer with nitinol stents: value, safety, and long-term results. AJR Am J Roentgenol 166 (1996) 79-84
26. Wong S.K.H., Chiu P., Leung S.F., et al. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case control study. Ann Surg Oncol 15 (2008) 576-582
27. Litle V.R., Luketich J.D., Christie N.A., et al. Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients. Ann Thorac Surg 76 (2003) 1687-1693
28. Dallal H.J., Smith G.D., Grieve D.C., Ghosh S., Penman I.D., and Palmer K.R. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc 54 (2001) 549-557
29. Spencer G.M., Thorpe S.M., Blackman G.M., et al. Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the esophagus and cardia: a randomized study. Gut 50 (2002) 224-227
30. Harver J.C., Fleischman E.H., Bellotti J.E., and Kagan A.R. Intracavitary radiation in treatment of advanced esophageal carcinoma: a comparison of high dose rate vs low dose rate brachytherapy. J Surg Oncol 52 (1993) 101-104
31. Sur R.K., Donde B., Levin V.C., and Mannell A. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys 40 (1998) 447-453
32. Sur R.K., Levin V.C., Donde B., Miszczyk L., and Nag S. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma-an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys 53 (2002) 127-133
33. Bergquist H., Wenger U., Johnsson E., et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled trial. Dis Esophagus 18 (2005) 131-139
34. Cwikiel W., Stridbeck H., Tranberg K., et al. Malignant esophageal strictures: treating with a self-expanding nitinol stent. Radiology 187 (1993) 661-665
35. Adam A., Ellul J., and Watkinson A. Palliation of inoperable esophageal carcinoma: a prospective randomized trial of laser therapy and stent placement. Radiology 202 (1997) 344-348
36. Siersema P.D., Hop W.C., van Blankenstein M., et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 54 (2001) 145-153
37. Mayoral W., Fleischer D., Salcedo J., Roy P., Al-Kawas F., and Benjamin S. Non-malignant obstruction is a common problem with metal stents in the treatment of esophageal cancer. Gastrointest Endosc 51 (2000) 556-559
38. Turkyilmaz A., Eroglu A., Subasi M., and Karaoglanoglu N. Clinicopathological features and prognosis of esophageal cancer in young patients. Is there a difference in outcome?. Dis Esophagus (2008) 10.1111/j.1442-2050.2008.00890.x published online November 12.
39. Hashemi N., Loren D., Dimarino A.J., and Cohen S. Presentation and prognosis of esophageal adenocarcinoma in patients below age 50. Dig Dis Sci (2008) 10.1007/s10620-008-0565-7 published online November 23.
40. Portale G., Peters J.H., Hseih C.C., et al. Esophageal adenocarcinoma in patients < or = 50 years old: delayed diagnosis and advanced disease at presentation. Am Surg 70 (2004) 954-958
41. Lu J.P., Xian M.S., and Hayashi K. Morphologic features in esophageal squamous cell carcinoma of young adults in north China. Cancer 74 (1994) 573-577